SLC22A6 (Q4U2R8) variants and mutations
SLC22A6 (also known as Q4U2R8) is a human protein-coding gene encoding a solute carrier family 22 member 6 protein. Its annotated function is secondary active transporter that functions as a Na(+)-independent organic anion (OA)/dicarboxylate antiporter where the uptake of one molecule of OA into the cell is coupled with an efflux of one molecule of intracellular dicarboxylate…. It is annotated at the basolateral cell membrane. This analysis covers 929 SLC22A6 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes gout, Hypertension, and endothelial dysfunction. Example SLC22A6 variants include A2D, A2S, and A2T.
Variant analysis overview
- Gene: SLC22A6
- Protein: Q4U2R8
- UniProt accession: Q4U2R8
- Organism: Homo sapiens
- Variants analyzed: 929
- Variant scope: all variants
- Completed: 2026-08-28
Variant and mutation evidence
- Variant composition: 686 unspecified-consequence records; 1 stop lost; 116 missense variants; 98 synonymous variants; 4 stop-gained variants; 3 in-frame deletions; 20 frameshift variants; 4 splice-region variants
- Prediction scores: 705 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: gout, Hypertension, endothelial dysfunction, pyelonephritis, Infertility, cellulitis, autoimmune disorder of central nervous system, heart failure, chronic kidney disease, uridine-cytidineuria, alcohol drinking, COVID-19.
Protein structure and variant hotspots
- Protein features: 12 transmembrane segments; 5 post-translational modification sites.
- Structural context: 408 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC22A6 variants
Examples include A2D, A2S, A2T, D5A, D5E, D5N, L6F, L6V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2D (p.Ala2Asp), ESP rs369844426, ExAC rs369844426, TOPMed rs369844426, gnomAD rs369844426, REVEL 0.21, MetaLR 0.34
- A2S (p.Ala2Ser), ExAC rs769827557, TOPMed rs769827557, gnomAD rs769827557, REVEL 0.13, MetaLR 0.21, Uncertain significance, not specified
- A2T (p.Ala2Thr), ExAC rs769827557, TOPMed rs769827557, gnomAD rs769827557, REVEL 0.06, MetaLR 0.17, Uncertain significance
- D5A (p.Asp5Ala), Ensembl rs1590681736
- D5E (p.Asp5Glu), ExAC rs746807941, gnomAD rs746807941, REVEL 0.05, MetaLR 0.03
- D5N (p.Asp5Asn), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- L6F (p.Leu6Phe), TOPMed rs2086300277, REVEL 0.35, MetaLR 0.39
- L6V (p.Leu6Val), NCI-TCGA TCGA novel, REVEL 0.26, MetaLR 0.22, Variant assessed as somatic; moderate impact.
- L7P (p.Leu7Pro), rs1415632329, UniProt VAR 039682, TOPMed rs1415632329, gnomAD rs1415632329, REVEL 0.58, MetaLR 0.53
- L7V (p.Leu7Val), TOPMed rs2086300236, gnomAD rs2086300236, REVEL 0.37, MetaLR 0.45
- Q8L (p.Gln8Leu), ExAC rs777512486, gnomAD rs777512486
- Q8P (p.Gln8Pro), ExAC rs777512486, gnomAD rs777512486, REVEL 0.05, MetaLR 0.07
- V10E (p.Val10Glu), Ensembl rs1590681712, REVEL 0.41, MetaLR 0.41
- V10G (p.Val10Gly), Ensembl rs1590681712
- G11E (p.Gly11Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G11R (p.Gly11Arg), TOPMed rs978637523
- G11V (p.Gly11Val), Ensembl rs2086299889
- G11W (p.Gly11Trp), TOPMed rs978637523
- G12A (p.Gly12Ala), ExAC rs754495560, TOPMed rs754495560, gnomAD rs754495560, REVEL 0.21, MetaLR 0.19
- G12S (p.Gly12Ser), gnomAD rs1167445352
- V13C (p.Val13Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V13G (p.Val13Gly), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- G14D (p.Gly14Asp), Ensembl rs868387276, REVEL 0.72, MetaLR 0.60
- G14S (p.Gly14Ser), cosmic curated COSV64560, ExAC rs72559735, TOPMed rs72559735, gnomAD rs72559735, REVEL 0.74, MetaLR 0.57
- G14V (p.Gly14Val), Ensembl rs868387276
- R15C (p.Arg15Cys), rs762097180, NCI-TCGA Cosmic COSV6456, cosmic curated COSV64561, ExAC rs762097180, REVEL 0.41, MetaLR 0.32, Variant assessed as somatic; moderate impact.
- R15H (p.Arg15His), rs751931872, ClinGen CA6059543, ClinVar RCV004329826, ExAC rs751931872, REVEL 0.27, MetaLR 0.20, Uncertain significance, not specified
- Q18K (p.Gln18Lys), TOPMed rs1447286981, gnomAD rs1447286981, REVEL 0.10, MetaLR 0.03
- Q18L (p.Gln18Leu), TOPMed rs2086299250, gnomAD rs2086299250, REVEL 0.11, MetaLR 0.03
- I19T (p.Ile19Thr), ExAC rs764496926, gnomAD rs764496926
- L23M (p.Leu23Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V25I (p.Val25Ile), TOPMed rs1210796361, gnomAD rs1210796361, REVEL 0.03, MetaLR 0.09
- L26R (p.Leu26Arg), TOPMed rs2086298869, gnomAD rs2086298869, REVEL 0.27, MetaLR 0.30
- P27A (p.Pro27Ala), gnomAD rs1215771795
- P27L (p.Pro27Leu), TOPMed rs1361999552, gnomAD rs1361999552, REVEL 0.45, MetaLR 0.36
- P27S (p.Pro27Ser), gnomAD rs1215771795, REVEL 0.39, MetaLR 0.36
- L28C (p.Leu28Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L28P (p.Leu28Pro), TOPMed rs1034098699, gnomAD rs1034098699, REVEL 0.31, MetaLR 0.22, Uncertain significance, not specified
- L28V (p.Leu28Val), ExAC rs769872326, gnomAD rs769872326, REVEL 0.05, MetaLR 0.06
- L29F (p.Leu29Phe), rs1328265782, NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, gnomAD rs1328265782, REVEL 0.04, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- L30Q (p.Leu30Gln), gnomAD rs1462177656, REVEL 0.47, MetaLR 0.44
- M31V (p.Met31Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A32V (p.Ala32Val), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10084, Variant assessed as somatic; moderate impact.
- S33F (p.Ser33Phe), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10084, Variant assessed as somatic; moderate impact.
- H34D (p.His34Asp), Ensembl rs929399612
- H34Q (p.His34Gln), TOPMed rs1168468419, gnomAD rs1168468419, REVEL 0.33, MetaLR 0.24
- T36A (p.Thr36Ala), TOPMed rs1001306753, gnomAD rs1001306753, REVEL 0.09, MetaLR 0.11
- T36I (p.Thr36Ile), gnomAD rs1430423222, REVEL 0.15, MetaLR 0.09
- T36P (p.Thr36Pro), TOPMed rs1001306753, gnomAD rs1001306753
- Q38R (p.Gln38Arg), gnomAD rs1476959704, REVEL 0.42, MetaLR 0.36
- N39K (p.Asn39Lys), TOPMed rs1457350534, gnomAD rs1457350534, REVEL 0.43, MetaLR 0.32
- T41I (p.Thr41Ile), gnomAD rs1214034828, REVEL 0.10, MetaLR 0.18
- A42S (p.Ala42Ser), gnomAD rs1255802272, REVEL 0.40, MetaLR 0.40
- A42V (p.Ala42Val), gnomAD rs1206154516, REVEL 0.53, MetaLR 0.40
- A43S (p.Ala43Ser), Ensembl rs1565288956
- P45A (p.Pro45Ala), NCI-TCGA Cosmic COSV6456, Variant assessed as somatic; moderate impact.
- P45S (p.Pro45Ser), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- T46P (p.Thr46Pro), gnomAD rs1022273869, REVEL 0.02, MetaLR 0.03
- H47L (p.His47Leu), ExAC rs771007235, TOPMed rs771007235, gnomAD rs771007235, REVEL 0.67, MetaLR 0.48
- H47N (p.His47Asn), ExAC rs776645979, TOPMed rs776645979, gnomAD rs776645979, REVEL 0.62, MetaLR 0.50
- H47P (p.His47Pro), ExAC rs771007235, TOPMed rs771007235, gnomAD rs771007235
- H48P (p.His48Pro), Ensembl rs1590681449, REVEL 0.31, MetaLR 0.34
- H48Q (p.His48Gln), cosmic curated COSV10747, ExAC rs747002284, gnomAD rs747002284, REVEL 0.32, MetaLR 0.32, Uncertain significance, not specified
- C49F (p.Cys49Phe), TOPMed rs973557519, gnomAD rs973557519, REVEL 0.53, MetaLR 0.44
- R50H (p.Arg50His), rs11568626, UniProt VAR 039683, 1000Genomes rs11568626, ESP rs11568626, REVEL 0.11, MetaLR 0.02, Benign
- R50L (p.Arg50Leu), 1000Genomes rs11568626, ESP rs11568626, ExAC rs11568626, TOPMed rs11568626, REVEL 0.09, MetaLR 0.16
- R50P (p.Arg50Pro), 1000Genomes rs11568626, ESP rs11568626, ExAC rs11568626, TOPMed rs11568626, REVEL 0.21, MetaLR 0.23
- P51L (p.Pro51Leu), gnomAD rs1023667224, REVEL 0.06, MetaLR 0.05
- P51S (p.Pro51Ser), gnomAD rs1463713596
- A53P (p.Ala53Pro), 1000Genomes rs201266950, ExAC rs201266950, TOPMed rs201266950, gnomAD rs201266950, REVEL 0.01, MetaLR 0.11
- A53S (p.Ala53Ser), 1000Genomes rs201266950, ExAC rs201266950, TOPMed rs201266950, gnomAD rs201266950, REVEL 0.01, MetaLR 0.12
- A53V (p.Ala53Val), ExAC rs753349251, gnomAD rs753349251, REVEL 0.04, MetaLR 0.10
- D54N (p.Asp54Asn), cosmic curated COSV64561, 1000Genomes rs149011842, ESP rs149011842, ExAC rs149011842, REVEL 0.04, MetaLR 0.03
- A55V (p.Ala55Val), rs202055464, ClinGen CA6059525, ClinVar RCV004127358, 1000Genomes rs202055464, REVEL 0.05, MetaLR 0.19, Uncertain significance, not specified
- N56Y (p.Asn56Tyr), gnomAD rs1178645936, REVEL 0.18, MetaLR 0.20
- L57P (p.Leu57Pro), TOPMed rs2086296265
- K59N (p.Lys59Asn), NCI-TCGA TCGA novel, TOPMed rs2086296200, Variant assessed as somatic; moderate impact.
- K59Q (p.Lys59Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N60S (p.Asn60Ser), Ensembl rs2086296152
- G61R (p.Gly61Arg), 1000Genomes rs199901321, ExAC rs199901321, TOPMed rs199901321, gnomAD rs199901321, REVEL 0.07, MetaLR 0.08
- G61W (p.Gly61Trp), 1000Genomes rs199901321, ExAC rs199901321, TOPMed rs199901321, gnomAD rs199901321, REVEL 0.07, MetaLR 0.21
- G62A (p.Gly62Ala), rs144803446, ClinGen CA6059517, ClinVar RCV004263685, ESP rs144803446, REVEL 0.03, MetaLR 0.08, Uncertain significance, not specified
- G62E (p.Gly62Glu), ESP rs144803446, ExAC rs144803446, TOPMed rs144803446, gnomAD rs144803446, Uncertain significance
- G62R (p.Gly62Arg), ExAC rs776839948, TOPMed rs776839948, gnomAD rs776839948, REVEL 0.05, MetaLR 0.06
- E64A (p.Glu64Ala), Ensembl rs1290313238
- E64G (p.Glu64Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V65A (p.Val65Ala), ExAC rs769533345, gnomAD rs769533345, REVEL 0.03, MetaLR 0.04
- V65D (p.Val65Asp), ExAC rs769533345, gnomAD rs769533345
- L67M (p.Leu67Met), TOPMed rs1202321551, gnomAD rs1202321551, REVEL 0.22, MetaLR 0.23
- P68H (p.Pro68His), TOPMed rs1472604813, REVEL 0.44, MetaLR 0.41
- P68S (p.Pro68Ser), gnomAD rs1374261331, REVEL 0.44, MetaLR 0.37
- R69G (p.Arg69Gly), 1000Genomes rs147795711, ESP rs147795711, ExAC rs147795711, TOPMed rs147795711, REVEL 0.07, MetaLR 0.14
- R69L (p.Arg69Leu), ESP rs144356509, ExAC rs144356509, TOPMed rs144356509, gnomAD rs144356509, Uncertain significance
- R69Q (p.Arg69Gln), rs144356509, cosmic curated COSV64560, ESP rs144356509, ExAC rs144356509, REVEL 0.07, MetaLR 0.07, Uncertain significance, not specified
- R69W (p.Arg69Trp), cosmic curated COSV64561, 1000Genomes rs147795711, ESP rs147795711, ExAC rs147795711, REVEL 0.06, MetaLR 0.14
- D70E (p.Asp70Glu), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64561, Variant assessed as somatic; moderate impact.
- D70G (p.Asp70Gly), TOPMed rs2086294941
- D70N (p.Asp70Asn), TOPMed rs1174200565, gnomAD rs1174200565, REVEL 0.05, MetaLR 0.10
- D70V (p.Asp70Val), TOPMed rs2086294941
- D70Y (p.Asp70Tyr), TOPMed rs1174200565, gnomAD rs1174200565, REVEL 0.30, MetaLR 0.29
- R71S (p.Arg71Ser), Ensembl rs2135103093
- R71T (p.Arg71Thr), TOPMed rs1163535824, gnomAD rs1163535824, REVEL 0.00, MetaLR 0.07
- Q72H (p.Gln72His), Ensembl rs2135103085, REVEL 0.01, MetaLR 0.07
- G73R (p.Gly73Arg), ExAC rs778178722, TOPMed rs778178722, gnomAD rs778178722, REVEL 0.21, MetaLR 0.16
- Q74* (p.Gln74Ter), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; high impact.
- Q74E (p.Gln74Glu), Ensembl rs1590681169
- E76D (p.Glu76Asp), NCI-TCGA TCGA novel, REVEL 0.02, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- E76G (p.Glu76Gly), Ensembl rs1040067762, REVEL 0.12, MetaLR 0.17
- E76K (p.Glu76Lys), ExAC rs758725291, gnomAD rs758725291, REVEL 0.11, MetaLR 0.17
- S77C (p.Ser77Cys), TOPMed rs2086294571, gnomAD rs2086294571, REVEL 0.23, MetaLR 0.32
- S77F (p.Ser77Phe), TOPMed rs2086294571, gnomAD rs2086294571, REVEL 0.20, MetaLR 0.29
- L79F (p.Leu79Phe), ExAC rs765693110, gnomAD rs765693110, REVEL 0.23, MetaLR 0.36
- R80C (p.Arg80Cys), rs1185293280, NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, gnomAD rs1185293280, REVEL 0.37, MetaLR 0.27, Variant assessed as somatic; moderate impact.
- R80H (p.Arg80His), rs755249293, ClinGen CA6059503, cosmic curated COSV64560, ClinVar RCV004451340, REVEL 0.14, MetaLR 0.14, Uncertain significance, not specified
- F81L (p.Phe81Leu), TOPMed rs1212228005, gnomAD rs1212228005, REVEL 0.28, MetaLR 0.21
- T82I (p.Thr82Ile), gnomAD rs1353606182, REVEL 0.07, MetaLR 0.10
- T82N (p.Thr82Asn), rs1353606182, NCI-TCGA Cosmic COSV6455, cosmic curated COSV64559, gnomAD rs1353606182, REVEL 0.07, MetaLR 0.12, Variant assessed as somatic; moderate impact.
- S83T (p.Ser83Thr), gnomAD rs2086294220, REVEL 0.03, MetaLR 0.06
- P84L (p.Pro84Leu), cosmic curated COSV64560, ExAC rs760859177, TOPMed rs760859177, gnomAD rs760859177, REVEL 0.34, MetaLR 0.30, Uncertain significance, not specified
- Q85* (p.Gln85Ter), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10084, Variant assessed as somatic; high impact.
- Q85P (p.Gln85Pro), ExAC rs761610586, gnomAD rs761610586, REVEL 0.13, MetaLR 0.11, Uncertain significance, not specified
- W86* (p.Trp86Ter), rs1234108606, NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, TOPMed rs1234108606, CADD 34.00, Variant assessed as somatic; high impact.
- W86L (p.Trp86Leu), Ensembl rs929283478
- L88V (p.Leu88Val), TOPMed rs1286217626, gnomAD rs1286217626, REVEL 0.12, MetaLR 0.14
- P89H (p.Pro89His), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- N92D (p.Asn92Asp), Ensembl rs959879694, REVEL 0.21, MetaLR 0.34
- N92K (p.Asn92Lys), TOPMed rs1186048147, gnomAD rs1186048147, REVEL 0.17, MetaLR 0.31
- N92S (p.Asn92Ser), ExAC rs748904249, TOPMed rs748904249, gnomAD rs748904249, REVEL 0.18, MetaLR 0.29
- G93D (p.Gly93Asp), Ensembl rs2086293551, REVEL 0.09, MetaLR 0.11
- T94I (p.Thr94Ile), gnomAD rs1160125762, REVEL 0.24, MetaLR 0.32
- T94K (p.Thr94Lys), gnomAD rs1160125762
- T94P (p.Thr94Pro), TOPMed rs1212609260, gnomAD rs1212609260, REVEL 0.25, MetaLR 0.27
- T94R (p.Thr94Arg), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10084, Variant assessed as somatic; moderate impact.
- E95K (p.Glu95Lys), Ensembl rs1590680976
- A96G (p.Ala96Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A96T (p.Ala96Thr), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- N97S (p.Asn97Ser), ExAC rs769257423, gnomAD rs769257423, REVEL 0.09, MetaLR 0.12
- G98D (p.Gly98Asp), Ensembl rs2086293247
- G100E (p.Gly100Glu), rs745391498, cosmic curated COSV10652, ExAC rs745391498, TOPMed rs745391498, REVEL 0.09, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- A101S (p.Ala101Ser), ExAC rs778287708, TOPMed rs778287708, gnomAD rs778287708, REVEL 0.02, MetaLR 0.10
- A101T (p.Ala101Thr), cosmic curated COSV64560, ExAC rs778287708, TOPMed rs778287708, gnomAD rs778287708, REVEL 0.03, MetaLR 0.11
- A101V (p.Ala101Val), TOPMed rs2086293048, REVEL 0.04, MetaLR 0.09
- P104L (p.Pro104Leu), rs11568627, UniProt VAR 047878, 1000Genomes rs11568627, ESP rs11568627, REVEL 0.21, MetaLR 0.28
- P104T (p.Pro104Thr), ExAC rs758821655, gnomAD rs758821655, REVEL 0.18, MetaLR 0.19
- T106I (p.Thr106Ile), TOPMed rs2086292796
- D107G (p.Asp107Gly), ExAC rs755443393, gnomAD rs755443393, REVEL 0.17, MetaLR 0.22
- D107N (p.Asp107Asn), rs565805838, ClinGen CA6059486, cosmic curated COSV10970, ClinVar RCV004091665, REVEL 0.12, MetaLR 0.13, Uncertain significance, not specified
- W109* (p.Trp109Ter), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; high impact.
- W109C (p.Trp109Cys), gnomAD rs1272873548, REVEL 0.68, MetaLR 0.83
- I110L (p.Ile110Leu), ExAC rs766737752, gnomAD rs766737752, REVEL 0.04, MetaLR 0.08
- I110M (p.Ile110Met), NCI-TCGA TCGA novel, Ensembl rs2086292487, REVEL 0.06, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- Y111F (p.Tyr111Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N113K (p.Asn113Lys), Ensembl rs1590680822
- S114G (p.Ser114Gly), Ensembl rs2135102628
- S114T (p.Ser114Thr), Ensembl rs1590680812
- T115N (p.Thr115Asn), TOPMed rs886137600, gnomAD rs886137600, REVEL 0.31, MetaLR 0.45
- T115S (p.Thr115Ser), TOPMed rs886137600, gnomAD rs886137600, REVEL 0.17, MetaLR 0.29
- F116I (p.Phe116Ile), Ensembl rs942215509
- F116L (p.Phe116Leu), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10084, NCI-TCGA Cosmic COSV6456, Variant assessed as somatic; moderate impact.
- P117Q (p.Pro117Gln), NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- S118P (p.Ser118Pro), Ensembl rs1565288562, REVEL 0.59, MetaLR 0.67
- T119A (p.Thr119Ala), 1000Genomes rs201905619
- I120F (p.Ile120Phe), ExAC rs761648281, gnomAD rs761648281, REVEL 0.90, MetaLR 0.73
- I120T (p.Ile120Thr), gnomAD rs1320230227, REVEL 0.87, MetaLR 0.71
- V121A (p.Val121Ala), gnomAD rs1323636484, REVEL 0.62, MetaLR 0.71
- V121M (p.Val121Met), cosmic curated COSV64560, 1000Genomes rs1389751480, gnomAD rs1389751480, REVEL 0.58, MetaLR 0.81
- T122I (p.Thr122Ile), gnomAD rs1341551456
- E123Q (p.Glu123Gln), TOPMed rs2086291666, gnomAD rs2086291666, REVEL 0.26, MetaLR 0.30
- D125E (p.Asp125Glu), ExAC rs764026395, TOPMed rs764026395, gnomAD rs764026395, REVEL 0.50, MetaLR 0.66, Uncertain significance, not specified
- V127G (p.Val127Gly), gnomAD rs1455872783
- V127M (p.Val127Met), gnomAD rs1192259936
- S129C (p.Ser129Cys), Ensembl rs2086287420, REVEL 0.40, MetaLR 0.59
- S129F (p.Ser129Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R131K (p.Arg131Lys), NCI-TCGA Cosmic COSV1008, NCI-TCGA Cosmic COSV6456, cosmic curated COSV64560, Variant assessed as somatic; moderate impact.
- A132T (p.Ala132Thr), gnomAD rs1181363799, REVEL 0.11, MetaLR 0.22
- R134C (p.Arg134Cys), ExAC rs752478205, REVEL 0.34, MetaLR 0.33
- R134H (p.Arg134His), cosmic curated COSV64561, 1000Genomes rs534797513, ExAC rs534797513, TOPMed rs534797513, REVEL 0.28, MetaLR 0.30
- Q135L (p.Gln135Leu), ExAC rs759080975, TOPMed rs759080975, gnomAD rs759080975, REVEL 0.36, MetaLR 0.28
- L136Q (p.Leu136Gln), TOPMed rs2086286950
- L136V (p.Leu136Val), TOPMed rs2086286999
Public SLC22A6 analysis runs
- SLC22A6 analysis run — SLC22A6 (929 variants) — completed 2026-08-28